FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice.

β-Cell compensation is an essential mechanism by which β-cells increase insulin secretion for overcoming insulin resistance to maintain euglycemia in obesity. Failure of β-cells to compensate for insulin resistance contributes to insulin insufficiency and overt diabetes. To understand the mechanism of β-cell compensation, we characterized the role of forkhead box O1 (FoxO1) in β-cell compensation in mice under physiological and pathological conditions. FoxO1 is a key transcription factor that serves as a nutrient sensor for integrating insulin signaling to cell metabolism, growth, and proliferation. We showed that FoxO1 improved β-cell compensation via 3 distinct mechanisms by increasing β-cell mass, enhancing β-cell glucose sensing, and augmenting β-cell antioxidative function. These effects accounted for increased glucose-stimulated insulin secretion and enhanced glucose tolerance in β-cell-specific FoxO1-transgenic mice. When fed a high-fat diet, β-cell-specific FoxO1-transgenic mice were protected from developing fat-induced glucose disorder. This effect was attributable to increased β-cell mass and function. Furthermore, we showed that FoxO1 activity was up-regulated in islets, correlating with the induction of physiological β-cell compensation in high-fat-induced obese C57BL/6J mice. These data characterize FoxO1 as a pivotal factor for orchestrating physiological adaptation of β-cell mass and function to overnutrition and obesity.

[1]  P. Reynolds,et al.  Insulin demand regulates β cell number via the unfolded protein response. , 2015, The Journal of clinical investigation.

[2]  D. Accili,et al.  Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function , 2015, Diabetes.

[3]  M. Prentki,et al.  Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. , 2014, Cell metabolism.

[4]  D. Accili,et al.  FOXO1 Inhibition Yields Functional Insulin-Producing Cells In Human Gut Organoid Cultures , 2014, Nature Communications.

[5]  T. Kitamura The role of FOXO1 in β-cell failure and type 2 diabetes mellitus , 2013, Nature Reviews Endocrinology.

[6]  Maike Sander,et al.  Inactivation of specific β cell transcription factors in type 2 diabetes. , 2013, The Journal of clinical investigation.

[7]  L. Alonso,et al.  Adaptive β-cell proliferation increases early in high-fat feeding in mice, concurrent with metabolic changes, with induction of islet cyclin D2 expression. , 2013, American journal of physiology. Endocrinology and metabolism.

[8]  Carly R. Kibbe,et al.  FOXO1 Competes with Carbohydrate Response Element-binding Protein (ChREBP) and Inhibits Thioredoxin-interacting Protein (TXNIP) Transcription in Pancreatic Beta Cells* , 2013, The Journal of Biological Chemistry.

[9]  Amy E. Cox,et al.  Human Pancreatic β-Cell G1/S Molecule Cell Cycle Atlas , 2013, Diabetes.

[10]  Katarzyna A. Broniowska,et al.  Differential responses of pancreatic β-cells to ROS and RNS. , 2013, American journal of physiology. Endocrinology and metabolism.

[11]  C. Talchai,et al.  Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure , 2012, Cell.

[12]  S. Ellard,et al.  SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion , 2012, Diabetologia.

[13]  Sylvia Lee Faculty Opinions recommendation of Generation of functional insulin-producing cells in the gut by Foxo1 ablation. , 2012 .

[14]  T. Kitamura,et al.  FoxO1 Gain of Function in the Pancreas Causes Glucose Intolerance, Polycystic Pancreas, and Islet Hypervascularization , 2012, PloS one.

[15]  T. Kitamura,et al.  Overexpression of FoxO1 in the hypothalamus and pancreas causes obesity and glucose intolerance. , 2012, Endocrinology.

[16]  Zhongming Ma,et al.  FTY720 Normalizes Hyperglycemia by Stimulating β-Cell in Vivo Regeneration in db/db Mice through Regulation of Cyclin D3 and p57KIP2* , 2011, The Journal of Biological Chemistry.

[17]  S. Ringquist,et al.  FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver , 2011, Diabetes.

[18]  D. Accili,et al.  FoxO Feedback Control of Basal IRS-2 Expression in Pancreatic β-Cells Is Distinct From That in Hepatocytes , 2011, Diabetes.

[19]  F. Ashcroft,et al.  Control of pancreatic β cell regeneration by glucose metabolism. , 2011, Cell metabolism.

[20]  A. F. Stewart,et al.  Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD–severe combined immunodeficiency (SCID) mice , 2011, Diabetologia.

[21]  J. Corbett,et al.  FoxO1 and SIRT1 Regulate β-Cell Responses to Nitric Oxide* , 2011, The Journal of Biological Chemistry.

[22]  S. Ringquist,et al.  FoxO1 links hepatic insulin action to endoplasmic reticulum stress. , 2010, Endocrinology.

[23]  J. Crapo,et al.  Redox Modulation Protects Islets From Transplant-Related Injury , 2010, Diabetes.

[24]  H. H. Dong,et al.  Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas , 2010, Diabetologia.

[25]  Jiang Hu,et al.  Cyclin D2 Is Essential for the Compensatory β-Cell Hyperplastic Response to Insulin Resistance in Rodents , 2010, Diabetes.

[26]  Huan Sun,et al.  Overexpression of FoxO1 causes proliferation of cultured pancreatic beta cells exposed to low nutrition. , 2010, Biochemistry.

[27]  R. DePinho,et al.  Regulation of Pancreatic Juxtaductal Endocrine Cell Formation by FoxO1 , 2009, Molecular and Cellular Biology.

[28]  D. Stoffers,et al.  Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion. , 2009, Molecular endocrinology.

[29]  I. Shiojima,et al.  mTORC1 Activation Regulates β-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability* , 2009, Journal of Biological Chemistry.

[30]  D. Harlan,et al.  Blood Glucose Levels Regulate Pancreatic β-Cell Proliferation during Experimentally-Induced and Spontaneous Autoimmune Diabetes in Mice , 2009, PloS one.

[31]  M. Laakso,et al.  Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[32]  M. Meseck,et al.  FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. , 2008, The Journal of clinical investigation.

[33]  R. Rizza,et al.  β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans , 2008, Diabetes.

[34]  M. Permutt,et al.  Inhibition of Foxo1 Protects Pancreatic Islet β-Cells Against Fatty Acid and Endoplasmic Reticulum Stress–Induced Apoptosis , 2008, Diabetes.

[35]  B. Topp,et al.  Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats. , 2007, American journal of physiology. Endocrinology and metabolism.

[36]  R. Kaufman,et al.  Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? , 2007, Antioxidants & redox signaling.

[37]  N. Zhang,et al.  Angiopoietin-1 Production in Islets Improves Islet Engraftment and Protects Islets From Cytokine-Induced Apoptosis , 2007, Diabetes.

[38]  Seung K. Kim,et al.  Glucose Infusion in Mice , 2007, Diabetes.

[39]  J. Altomonte,et al.  PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1 , 2007 .

[40]  D. Accili,et al.  Metabolic Diapause in Pancreatic β-Cells Expressing a Gain-of-function Mutant of the Forkhead Protein Foxo1* , 2007, Journal of Biological Chemistry.

[41]  H. Aburatani,et al.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. , 2007, The Journal of clinical investigation.

[42]  J. Altomonte,et al.  Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. , 2006, Endocrinology.

[43]  Min-Seon Kim,et al.  Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis , 2006, Nature Neuroscience.

[44]  M. Prentki,et al.  Islet beta cell failure in type 2 diabetes. , 2006, The Journal of clinical investigation.

[45]  Hua V. Lin,et al.  Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. , 2006, The Journal of clinical investigation.

[46]  H. Kaneto,et al.  The Forkhead Transcription Factor Foxo1 Bridges the JNK Pathway and the Transcription Factor PDX-1 through Its Intracellular Translocation* , 2006, Journal of Biological Chemistry.

[47]  Robert Tjian,et al.  Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. , 2005, Genes & development.

[48]  D. Accili,et al.  FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. , 2005, Cell metabolism.

[49]  Hendrik C Korswagen,et al.  Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling , 2005, Science.

[50]  P. B. Jensen,et al.  The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  U. Boggi,et al.  Functional and molecular defects of pancreatic islets in human type 2 diabetes. , 2005, Diabetes.

[52]  R. Robertson Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes* , 2004, Journal of Biological Chemistry.

[53]  B. Topp,et al.  Metabolic adaptations to chronic glucose infusion in rats , 2004, Diabetologia.

[54]  D. Accili,et al.  FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and Transformation , 2004, Cell.

[55]  M. Lane,et al.  Convergence of Peroxisome Proliferator-activated Receptor γ and Foxo1 Signaling Pathways* , 2003, Journal of Biological Chemistry.

[56]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[57]  Y. Kido,et al.  The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. , 2002, The Journal of clinical investigation.

[58]  D. Accili,et al.  Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.

[59]  S. Aizawa,et al.  Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.

[60]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[61]  J. Leahy,et al.  The loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment. , 1992, The Journal of clinical investigation.

[62]  J. Leahy,et al.  Compensatory Growth of Pancreatic β-Cells in Adult Rats After Short-Term Glucose Infusion , 1989, Diabetes.

[63]  A. Tannapfel,et al.  Cell cycle control of β-cell replication in the prenatal and postnatal human pancreas. , 2011, American journal of physiology. Endocrinology and metabolism.

[64]  R. Robertson,et al.  Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .